Pfizer's quarterly financial report on Tuesday comes at a critical moment for the U.S. drugmaker and its CEO, as activist hedge fund Starboard Value ramps up the pressure to demonstrate concrete results of a promised turnaround. https://t.co/iGhUUOVCEs https://t.co/iGhUUOVCEs
#Pfizer management looks to show turnaround as Starboard looms https://t.co/rUxeAgRiAM
💊 📉 Pfizer aims for turnaround as Starboard pressure mounts ahead of quarterly results Tickers of interest: $PFE Full Story → https://t.co/wi5QxtF870 https://t.co/AMaJsFvRnH

Pfizer is facing increased pressure from activist hedge fund Starboard Value ahead of its quarterly financial report on Tuesday. The U.S. drugmaker and its CEO are under scrutiny to demonstrate concrete results of a promised turnaround. This comes as Pfizer's management aims to show a positive shift in performance, despite concerns that the activist battle might fizzle. The stock of Pfizer, trading under the ticker $PFE, remains a focal point for investors.